What your 99215 actually pays: Medicare's 2026 rate for the highest E/M level

The level-5 established-patient visit is reserved for the most complex medication-management encounters: multiple unstable conditions, high-risk decisions, real time on the clock. Medicare raised it 9.5% for 2026, the largest percentage gain in the E/M family, and it is the code most practices under-document.

The code, and why it is rare

CPT code 99215 is the level-5 established-patient office visit: 40 to 54 minutes of total time, or medical decision-making (MDM) classified as high complexity. High complexity generally means multiple chronic conditions that are worsening or unstable, a decision involving significant risk (starting or stopping a medication with serious side-effect potential, managing suicidal ideation, cross-titrating two psychiatric medications at once), or both. A patient mid-crisis, on three medications being actively adjusted, seen for 45 minutes while the clinician works through a real risk decision, is a textbook 99215.

It is also the E/M level clinicians most often avoid billing even when the visit supports it. The instinct to round down, to call a hard visit a 99214 because it feels safer to defend, is common and expensive. Every 99215 billed as a 99214 gives away real money on a visit that already took the extra time.

What Medicare pays in 2026

Medicare pays $192.39 nationally for 99215 in 2026, up from $175.64 in 2025, a 9.5% increase, the largest percentage jump across the established-patient E/M family this year. The number underneath that move is the Medicare conversion factor, a single dollar multiplier that CMS applies to every code on the physician fee schedule. It fell for five straight years, from a peak of $36.09 in 2020 to $32.35 in 2025, before this year's rule reversed course: $33.40 for 2026, a 3.26% increase. E/M codes were explicitly exempted from a separate 2.5% efficiency cut CMS applied elsewhere in the same rule.

What commercial payers pay

PayerPrice shows national average commercial rates for 99215 from $165.55 (Aetna) to $198.27 (Cigna) as of August 2026. Unlike 99214, where Cigna is the only major payer paying above Medicare, every major commercial payer in the PayerPrice data pays close to or above the 2026 Medicare rate for 99215, which makes it one of the few codes in this family where commercial reimbursement broadly keeps pace with the government rate.

The so-what

99215 is also a magnet for payer scrutiny precisely because it pays the most: Medicare Advantage plans and commercial payers increasingly flag high-level E/M codes, 99214 and 99215 specifically, for automated review. That makes documentation discipline the whole game. The code has to be defensible on the day you bill it, not reconstructed later.

• Document the complexity in the moment. If a visit involves multiple unstable conditions or a high-risk medication decision, the note needs to say so specifically, not just describe the med change.
• Track your 99215 rate against your acuity. A panel with real crisis-level patients and zero 99215 claims is very likely under-coding, not conservatively coding.